Safety of off‐label dose reduction of non‐vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

AIM: To investigate the effects of off‐label non‐vitamin K oral anticoagulant (NOAC) dose reduction compared with on‐label standard dosing in atrial fibrillation (AF) patients in routine care. METHODS: Population‐based cohort study using data from the United Kingdom Clinical Practice Research Datali...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Dries, Carline J., Pajouheshnia, Romin, van den Ham, Hendrika A., Souverein, Patrick, Moons, Karel G. M., Hoes, Arno W., Geersing, Geert‐Jan, van Doorn, Sander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091743/
https://www.ncbi.nlm.nih.gov/pubmed/36102068
http://dx.doi.org/10.1111/bcp.15534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091743/
https://www.ncbi.nlm.nih.gov/pubmed/36102068
http://dx.doi.org/10.1111/bcp.15534

Ejemplares similares